Immunostimulants and prevention of recurrent respiratory respiratory tract infections

Susanna Esposito, A. Musio

Research output: Contribution to journalArticlepeer-review

Abstract

Recurrent respiratory tract infections (RRTIs) are very common in children and a major challenge for pediatricians. They affect the children's quality of life, cause absences from school and lost parental working days, and repeated medical examinations, hospital admissions as well as antibiotic therapies lead to high costs for society. Given their prevalence and clinical importance, various prevention strategies have been developed. One of the most widely used is the administration of immunostimulants: i.e. molecules of bacterial or synthetic origin that interact with immunological mechanisms in vitro and in vivo. A number of studies have investigated their effects on cellular and innate immunity, and their clinical efficacy, but there is no consensus as to their real usefulness. The main aim of this review is to analyse the available data concerning the activity and efficacy of immunostimulants in preventing pediatric RRTIs. The majority of studies have shown that the number of infections decreases after immunostimulant treatment, but they are affected by various methodological weaknesses. Further studies are urgently needed to confirm whether, when and which immunostimulants should be used.

Original languageEnglish
Pages (from-to)627-636
Number of pages10
JournalJournal of Biological Regulators and Homeostatic Agents
Volume27
Issue number3
Publication statusPublished - 2013

Keywords

  • Immucytal
  • Immunostimulants
  • OM-85 BV
  • Pidotimod
  • Prevention
  • Recurrent respiratory tract infections

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Cancer Research
  • Immunology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Immunology and Allergy
  • Medicine(all)

Fingerprint Dive into the research topics of 'Immunostimulants and prevention of recurrent respiratory respiratory tract infections'. Together they form a unique fingerprint.

Cite this